SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-008737
Filing Date
2019-09-30
Accepted
2019-09-30 16:11:30
Documents
12
Period of Report
2019-09-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20190926x8k.htm   iXBRL 8-K 34072
  Complete submission text file 0001558370-19-008737.txt   152558

Data Files

Seq Description Document Type Size
2 EX-101.SCH edit-20190926.xsd EX-101.SCH 3280
3 EX-101.LAB edit-20190926_lab.xml EX-101.LAB 15499
4 EX-101.PRE edit-20190926_pre.xml EX-101.PRE 10520
8 EXTRACTED XBRL INSTANCE DOCUMENT edit-20190926x8k_htm.xml XML 4678
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 191126203
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences